2159 — Mediwelcome Healthcare Management & Technology Income Statement
0.000.00%
Last trade - 00:00
- HK$79.00m
- HK$22.83m
- CNY331.31m
- 18
- 57
- 21
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 427 | 432 | 708 | 323 | 331 |
Cost of Revenue | |||||
Gross Profit | 94.9 | 96.3 | 93.6 | 32.6 | 29.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 395 | 408 | 709 | 410 | 421 |
Operating Profit | 32.4 | 24.3 | -0.768 | -86.4 | -89.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 26 | 22.3 | 5.59 | -91 | -96.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22.1 | 22 | 5.2 | -93.7 | -96.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 20.9 | 21 | 4.64 | -89.2 | -94.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 20.9 | 21 | 4.64 | -89.2 | -94.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.162 | 0.197 | 0.071 | -0.469 | -0.359 |